NCT00003149View on ClinicalTrials.gov

Interleukin-12 in Treating Patients With Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 1997

Study Completion Date

September 30, 2006

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
BIOLOGICAL

recombinant interleukin-12

Trial Locations (10)

14642

University of Rochester Cancer Center, Rochester

46202

Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis

55905

Mayo Clinic Cancer Center, Rochester

70121

CCOP - Ochsner, New Orleans

46202-5289

Indiana University Cancer Center, Indianapolis

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

08822

Hunterdon Regional Cancer Center, Flemington

07962-1956

Morristown Memorial Hospital, Morristown

07902-0220

Overlook Hospital, Summit

19102-1192

Hahnemann University Hospital, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00003149 - Interleukin-12 in Treating Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter